Clinical Trial Update: Trial of Chemoradiation and Pembrolizumab in Patients With Rectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating chemoradiation with pembrolizumab for rectal cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: Osama Rahma, MD | Conditions: Rectal Cancer, Rectal Neoplasm | Phase 2 | Status: WITHDRAWN